ncRNA name
hsa-miR-125b
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
HAX-1
Cancer name
Breast Cancer
Cancer site
Breast
Treatment type
Chemotherapy
Drug
Doxorubicin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Up
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
It was demonstrated that the overexpression of miR-125b increased the sensitivity of MCF-7/R cells to DOX.
Tissue resource
pairs of breast cancer tumor and corresponding adjacent non-tumor tissues
Experiment
qRT-PCR,Western blot,Luciferase reporter assay
Institute
Dongyang People's Hospital
Country
China
Continent
Asia